The Recall Desk
LowFDA (Devices)·Z-0516-2016·Announced 2015-12-30

Ameditech ProScreen 10 Panel Cup Recall for Reduced Benzodiazepine Reactivity

Ameditech is recalling ProScreen 10 Panel Cups because they may show reduced reactivity for two specific benzodiazepine compounds.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The agency classification is Class III, which by definition indicates the product is unlikely to cause adverse health consequences. The issue is a performance defect (reduced reactivity) rather than a direct physical hazard.

Plain-English summary

Ameditech Inc is recalling 3,411 kits of the ProScreen 10 Panel Cup (Item No. PSCup-10M). The affected products were distributed nationwide. The recall involves specific lot codes listed in the agency record.

The recall is due to reduced reactivity for up to two of the nineteen benzodiazepine compounds for which specificity information is provided in the product insert. The specific compounds with potential reduced reactivity are Clonazepam and Chlordiazepoxide. This issue may affect the accuracy of drug-of-abuse test results for these specific substances.

Consumers and healthcare providers should stop using the affected kits and contact Ameditech Inc for further instructions or a replacement.

The recalled product

Product
ProScreen 10 Panel Cup, Item No. PSCup-10M
Manufacturer
Ameditech Inc
Affected units
3,411

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 59 products in this recall →